Illumina said the NextSeq 2000 and NextSeq 1000 reduce run costs by up to 50 percent, compared to the NextSeq 550 model, while increasing the data output.
Genentech will use Adaptive's ClonoSeq assay for MRD testing in a CLL study. Adaptive will receive upfront and sample testing payments of undisclosed amounts.
Researchers have made gene-edited tomatoes that grow in bunches like grapes, as Popular Mechanics reports.
Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors.
The company was founded by Washington State University scientists to offer molecular breeding and genomic services for cannabis cultivation.
Among other projects, the partners plan to establish a large-scale tropical plant genomics R&D center and associated sequencing and bioinformatics infrastructure.
The funding, provided in partnership with Agriculture and Agri-food Canada, will support research applying genomics in agriculture and aquaculture.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
Arev holding company BC Bud Depot will use Lighthouse Genomics' cannabis-specific microarray for high-throughput genotyping.
The agriculture company said it will use the technology it has licensed for new applications in crop editing and for research to bring new foods to market.
A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.
Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.
Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.
In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.